Proud to share that Part the Cloud is investing nearly $7 million in 5 promising Alzheimer's therapies to help move them into clinical trials — combination strategies, a repurposed diuretic and our first AI-designed antibody therapy. Learn more: bit.ly/4ruxb02
Maria C Carrillo PhD
@DrMariaALZ
Chief Science Officer & Medical Affairs Lead
305 Following 3.8K Followers 1.3K Posts
Latest posts 5
4 FDA-cleared blood tests for Alzheimer's diagnosis & 2 cleared within a few days of each other. It's the kind of progress we've been working toward for decades. This is the research community doing what it does best: turning ideas and discovery into real tools for real people.
Breaking News: Today, the U.S. Food and Drug Administration (FDA) cleared a fourth Alzheimer’s blood test for people experiencing signs or symptoms of cognitive impairment. This is the second blood-based biomarker test to be cleared in the past week.View quoted post on X
Read our statement: bit.ly/3SMm6KO.
Advances like this matter for people and families seeking answers. See below for our full statement.
📰 Breaking News: The U.S. Food and Drug Administration (FDA) has cleared the third Alzheimer's blood test for individuals experiencing signs or symptoms of cognitive impairment. This is the first blood test cleared for use in patients as young as 40.View quoted post on X
Read our full statement: bit.ly/3TZ8fBg.
At #AAIC26 last week, we announced PROTECT-Cog to evaluate whether combining lifestyle intervention with a metabolism-targeting drug like a GLP-1 agonist can further reduce dementia risk. That’s a $100 million commitment – in science, progress, and people.
📰 Today the Association announced the launch of the PROTECT-Cog Study to test U.S. POINTER lifestyle and GLP-1 or similar drug to cut risk of cognitive decline. Learn More: bit.ly/4pekZiJView quoted post on X
This LatAm-FINGERS news from #AAIC26 is big. Not just for science, but for the power of global scientific collaboration. Check out The Lancet paper!
thelancet.com/journals/lance…
thelancet.com/journals/lance…
📰 Breaking news from #AAIC26: Lifestyle program improves brain health among older adults at risk for dementia across Latin America — confirming and expanding Alzheimer’s Association-funded U.S. POINTER Trial results. Learn More: bit.ly/4f7dJ3zView quoted post on X